Zhou Q, Huang T, Jiang Z, Ge C, et al. Correction: Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway. Oncogene 2020 Sep 7. pii: 10.1038/s41388-020-01440.
PMID: 32895479